drugset / Trial / NCT00080236
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to test the safety and effectiveness of IDN-6556 in preventing liver damage that normally occurs when livers are transported before being transplanted and in the immediate post-transplant period.
Timeline
- Start
- 2003-11
- Primary completion
- 2006-01
- Completion
- 2006-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Emricasan | Small molecule | 5 ug/ml | — |
| Comparator | Emricasan | Small molecule | 15 ug/ml | — |
| Comparator | Emricasan | Small molecule | 0.5 mg/kg | — |